Total Valuation
PolyPeptide Group AG has a market cap or net worth of $1.76B. The enterprise value is $1.63B.
Market Cap$1.76B
Enterprise Value$1.63B
Share Statistics
PolyPeptide Group AG has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PolyPeptide Group AG’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is 1.14%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)1.14%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee268.40K
Profits Per Employee-14.50K
Employee Count1,460
Asset Turnover0.47
Inventory Turnover2.13
Valuation Ratios
The current PE Ratio of PolyPeptide Group AG is 110.5. PolyPeptide Group AG’s PEG ratio is -5.17.
PE Ratio110.5
PS Ratio2.36
PB Ratio2.72
Price to FCF-30.38
Price to Operating Cash Flow29.84
PEG Ratio-5.17
Income Statement
In the last 12 months, PolyPeptide Group AG had revenue of 391.87M and earned -21.31M in profits. Earnings per share was -0.64.
Revenue391.87M
Gross Profit64.32M
Operating Income7.41M
Pretax Income-21.41M
Net Income-21.31M
EBITDA45.48M
Earnings Per Share (EPS)-0.64
Cash Flow
In the last 12 months, operating cash flow was 52.60M and capital expenditures -102.35M, giving a free cash flow of -49.75M billion.
Operating Cash Flow52.60M
Free Cash Flow-49.75M
Free Cash Flow per Share-10.00T>
Dividends & Yields
PolyPeptide Group AG pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-162907.86
52-Week Price Change35.18%
50-Day Moving Average53.69
200-Day Moving Average―
Relative Strength Index (RSI)49.36
Average Volume (3m)0.00
Important Dates
PolyPeptide Group AG upcoming earnings date is Mar 9, 2027, TBA (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateMar 9, 2027
Ex-Dividend Date―
Financial Position
PolyPeptide Group AG as a current ratio of 1.74, with Debt / Equity ratio of 39.60%
Current Ratio1.74
Quick Ratio0.91
Debt to Market Cap0.12
Net Debt to EBITDA1.23
Interest Coverage Ratio0.40
Taxes
In the past 12 months, PolyPeptide Group AG has paid -106.69K in taxes.
Income Tax-106.69K
Effective Tax Rate<0.01
Enterprise Valuation
PolyPeptide Group AG EV to EBITDA ratio is 21.56, with an EV/FCF ratio of -32.22.
EV to Sales2.50
EV to EBITDA21.56
EV to Free Cash Flow-32.22
EV to Operating Cash Flow12.57
Balance Sheet
PolyPeptide Group AG has $59.21M in cash and marketable securities with $139.52M in debt, giving a net cash position of -$80.30M billion.
Cash & Marketable Securities$59.21M
Total Debt$139.52M
Net Cash-$80.30M
Net Cash Per Share-$10.00T>
Tangible Book Value Per Share$9.89
Margins
Gross margin is 22.58%, with operating margin of 1.89%, and net profit margin of -5.44%.
Gross Margin22.58%
Operating Margin1.89%
Pretax Margin-5.46%
Net Profit Margin-5.44%
EBITDA Margin11.61%
EBIT Margin1.89%
Analyst Forecast
The average price target for PolyPeptide Group AG is $53.39, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$53.39
Price Target Upside-1.35% Downside
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast33.50%
EPS Growth Forecast―